Head-To-Head Comparison: Adagio Medical (ADGM) vs. Its Competitors

Adagio Medical (NASDAQ:ADGM) is one of 142 public companies in the “MED INSTRUMENTS” industry, but how does it compare to its peers? We will compare Adagio Medical to related businesses based on the strength of its institutional ownership, earnings, profitability, risk, valuation, analyst recommendations and dividends.

Volatility and Risk

Adagio Medical has a beta of 0.14, indicating that its stock price is 86% less volatile than the S&P 500. Comparatively, Adagio Medical’s peers have a beta of 1.89, indicating that their average stock price is 89% more volatile than the S&P 500.

Valuation and Earnings

This table compares Adagio Medical and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Adagio Medical	$600,000.00	-$75.04 million	-1.78
Adagio Medical Competitors	$1.73 billion	$195.96 million	2.67

Adagio Medical’s peers have higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Adagio Medical and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-248.26%	-125.31%
Adagio Medical Competitors	-182.36%	-90.09%	-20.54%

Insider & Institutional Ownership

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 54.1% of shares of all “MED INSTRUMENTS” companies are owned by institutional investors. 53.5% of Adagio Medical shares are owned by insiders. Comparatively, 14.4% of shares of all “MED INSTRUMENTS” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current recommendations for Adagio Medical and its peers, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1	0	0	0	1.00
Adagio Medical Competitors	1163	3794	7130	265	2.53

As a group, “MED INSTRUMENTS” companies have a potential upside of 20.65%. Given Adagio Medical’s peers stronger consensus rating and higher probable upside, analysts clearly believe Adagio Medical has less favorable growth aspects than its peers.

Summary

Adagio Medical peers beat Adagio Medical on 11 of the 13 factors compared.

Adagio Medical Company Profile

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.